Salmonella is the scientific name for over 2,500 types of bacteria. They are known to cause disease in humans, animals, and birds (especially poultry) worldwide. People can acquire the bacteria via a variety of different foods of animal origin. The illness it causes is called salmonellosis.
The Salmogenics vaccine is a patented vaccine for Salmonella. Salmogenics stimulates an immune response in chickens produced from inoculated eggs to fight several intestinal pathogenic organisms that include seven field strains of E. coli and four Salmonella strains.
Salmogenics contains the Sotomayor Antigen, which has been patented by the Company’s majority shareholder, NHIL. An antigen is a substance that, when introduced into a body, triggers the production of an antibody by the immune system, which will then kill or neutralize the antigen that is recognized as a foreign and potentially harmful invader. The Sotomayor Antigen pertains to a particular composition of multiple germs mainly of the Genus Salmonella in order to control intestinal pathogenic organisms in the chicken species.
The chicken egg, when properly vaccinated with Salmogenics, we believe, hatches a Salmonella-resistant chick that requires fewer antibiotics. To the consumer, this may mean a higher quality meat grown with fewer antibiotics.